Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Vensun Pharmaceuticals hired Joan Janulis as senior vice president, regulatory affairs and compliance. Previously, she worked at Lachman Consultants, as well as Faulding/Purepac Pharmaceutical, Ivax Pharmaceuticals, and Able Laboratories.

Alnylam Pharmaceuticals hired Dr. Alex Leather as general manager for the EU and Canada;


Alnylam Pharmaceuticals hired Alfred Boyle as senior vice president, technical operations;

Alnylam Pharmaceuticals hired Akin Akinc as general manager for the Fitusiran product;


Therapeutic Proteins International hired Michael Washabaugh as chief scientific officer;

C4 Therapeutics hired Thomas Needham Jr. as chief business officer;

Aeterna Zentaris named Genevieve Lemaire as vice president, finance and chief accounting officer;

Espero Pharmaceuticals named Jeff Cole as president and chief financial officer;

Espero Pharmaceuticals named Sean Purdy as vice president of commercial operations;

Protagonist Therapeutics hired Thomas O’Neil as chief financial officer;

Neothetics says that George Mahaffey resigned as chief executive officer;

TissueGene hired Dr. Gurdyal Kalsi as chief medical officer and senior VP, clinical development;

Opiant Pharmaceuticals hired Mark Ellison as executive VP, development, manufacturing & quality;

Recro Pharma hired Fred Graff as chief commercial officer;

Tocagen hired John Wood as vice president of regulatory affairs and quality assurance;

Nutra Pharma hired Thomas Northrop as senior commercial development officer;

Sunesis Pharmaceuticals promoted Deborah Thomas to senior VP, regulatory affairs and quality assurance;

Regeneron Pharmaceuticals says Douglas McCorkle will retire as vice president, controller in early 2017.